CDC42EP1 Recombinant Rabbit Monoclonal Antibody [SD08-54]
cat.: ET1612-95
Product Type: Recombinant Rabbit monoclonal IgG, primary antibodies
Species reactivity: Human
Applications: WB
Clonality: Monoclonal
Clone number: SD08-54
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
Storage buffer: 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 40 kDa
Isotype: IgG
Immunogen: Synthetic peptide within Human CDC42EP1 aa 310-359 / 391.
Positive control: HeLa cell lysate, HUVEC cell lysate, HEK-293 cell lysate, K-562 cell lysate.
Subcellular location: Endomembrane system, Cytoplasm.
Recommended Dilutions:
  WB

1:5,000
Uniprot #: SwissProt: Q00587 Human
Alternative names: 55 kDa bone marrow stromal/endothelial cell protein Binder of Rho GTPases 5 Bone marrow stromal/endothelial cell protein, 55-KD BORG 5 BORG5 BORG5_HUMAN CDC42 effector protein (Rho GTPase binding) 1 Cdc42 effector protein 1 Cdc42ep1 CEP 1 CEP1 MGC15316 MSE 55 MSE55 OTTHUMP00000028709 Serum constituent protein Serum protein MSE55
Images
ET1612-95_1.jpg Fig1: Western blot analysis of CDC42EP1 on different lysates with Rabbit anti-CDC42EP1 antibody (ET1612-95) at 1/5,000 dilution.

Lane 1: HeLa cell lysate
Lane 2: HUVEC cell lysate
Lane 3: HEK-293 cell lysate
Lane 4: K-562 cell lysate

Lysates/proteins at 20 µg/Lane.

Predicted band size: 40 kDa
Observed band size: 60 kDa

Exposure time: 10 seconds; ECL: K1801;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1612-95) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.